INTELLIGENT BIO SOLUTIONS INC. Income (Loss) from Equity Method Investments
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Income (Loss) from Equity Method Investments of -$135.69 thousand for the 12-month period ending 2021-06-30, per its 10-K filed 2022-09-22.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2022-09-22
- INTELLIGENT BIO SOLUTIONS INC. income (loss) from equity method investments for the quarter ending 2021-06-30 was $0.00.
- INTELLIGENT BIO SOLUTIONS INC. income (loss) from equity method investments for the quarter ending 2021-03-31 was $0.00.
- INTELLIGENT BIO SOLUTIONS INC. income (loss) from equity method investments for the quarter ending 2020-12-31 was $0.00.
- INTELLIGENT BIO SOLUTIONS INC. income (loss) from equity method investments for the quarter ending 2020-09-30 was -$135.69K.
- INTELLIGENT BIO SOLUTIONS INC. income (loss) from equity method investments for fiscal 2021 was -$135.69K, a 211.50% decline from fiscal 2020.
- INTELLIGENT BIO SOLUTIONS INC. income (loss) from equity method investments for fiscal 2020 was $121.69K.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|
| 2021-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-22 | $0.00 derived: sum of 2 quarters · filed 2022-09-22 | $0.00 derived: sum of 3 quarters · filed 2022-09-22 | -$135.69K 10-K · filed 2022-09-22 |
| 2021-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | $0.00 derived: sum of 2 quarters · filed 2022-05-16 | -$135.69K 10-Q · filed 2022-05-16 | |
| 2020-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-11 | -$135.69K 10-Q · filed 2022-02-11 | ||
| 2020-09-30 | -$135.69K 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | $121.69K 10-K · filed 2021-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |